ACRS (Aclaris Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on ACRS (Aclaris Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

ACRS

Aclaris Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates
Nov 6, 2025
Aclaris: Q3 Earnings Snapshot
Nov 6, 2025
Aclaris Therapeutics (NASDAQ:ACRS) adds US$40m to market cap in the past 7 days, though investors from three years ago are still down 83%
Nov 2, 2025
Aclaris Therapeutics to Participate in Three November Healthcare Conferences
Oct 29, 2025
What Makes Aclaris Therapeutics (ACRS) a Strong Momentum Stock: Buy Now?
Oct 21, 2025
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025
Sep 30, 2025
Acadian Increases Stake in Aclaris Therapeutics, Inc. (ACRS) as Phase 2a Data Gains Spotlight
Sep 21, 2025
Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress
Sep 9, 2025
This Aclaris Therapeutics Insider Increased Their Holding By 1,537% Last Year
Aug 31, 2025
Aclaris Therapeutics to Participate in Two September Healthcare Conferences
Aug 27, 2025
Aclaris Therapeutics Reports Positive Phase 2a Clinical Trial Results for ATI-2138
Aug 18, 2025
Earnings Beat: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 10, 2025
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates
Aug 7, 2025
Aclaris: Q2 Earnings Snapshot
Aug 7, 2025

Reviews